Bio Spectrum - July 2024Add to Favorites

Bio Spectrum - July 2024Add to Favorites

Magzter GOLDで読み放題を利用する

1 回の購読で Bio Spectrum と 9,000 およびその他の雑誌や新聞を読むことができます  カタログを見る

1 ヶ月 $9.99

1 $99.99 $49.99

$4/ヶ月

保存 50%
Hurry, Offer Ends in 12 Days
(OR)

のみ購読する Bio Spectrum

1年$11.88 $7.99

Holiday Deals - 保存 33%
Hurry! Sale ends on January 4, 2025

この号を購入 $0.99

ギフト Bio Spectrum

7-Day No Questions Asked Refund7-Day No Questions
Asked Refund Policy

 ⓘ

Digital Subscription.Instant Access.

デジタル購読。
インスタントアクセス。

Verified Secure Payment

検証済み安全
支払い

この問題で

MediTech Stackathon 2024 to Drive Explosive Growth
India's medtech industry holds immense potential, with projections estimating a growth rate of 28 per cent annually, reaching a size of $50 billion by 2030. Currently, India is the fourth largest market for medical devices in Asia and among the top 20 globally. Net imports for 2022-23 stands at $4.101 billion with import coverage ratio of 0.45. The sector has witnessed a surge in imports, driven primarily by countries like the US, China, and Germany, however, India's robust policy ecosystem presents opportunities for exports and reducing import dependence through domestic manufacturing. Exports have overtaken imports in consumables and disposables during last year. The industry now needs to continue with the momentum in other pillars of the medtech sector. Against this backdrop of immense potential, the Department of Pharmaceuticals launched Meditech Stackathon 2024, which
seeks to harness the collective expertise of stakeholders to propel the industry towards unprecedented heights of innovation and self-reliance. With optimal support and participation from all stakeholders, initiatives like Meditech Stackathon will take the Indian medtech industry to the next levels to become self-reliant.

Bio Spectrum Magazine Description:

出版社MM Activ Sci-Tech Communication

カテゴリーBusiness

言語English

発行頻度Monthly

India's leading publication that covers the business of bio-technology. With comprehensive analyses of policy issues, products and services across the bio-pharma, bio-informatics, bio-infrastructure and bio-agriculture segments, it is the industry's most authoritative source of information.

  • cancel anytimeいつでもキャンセルOK [ 契約不要 ]
  • digital onlyデジタルのみ